Overview

Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia

Status:
Terminated
Trial end date:
2020-09-03
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy of 2 fixed-flexible doses of Lu AF11167 on negative symptoms in patients with schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
H. Lundbeck A/S